Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors

NCT00602082 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

84

Enrollment

OTHER

Sponsor class

Conditions

Gastrointestinal Carcinoid Tumor
Islet Cell Tumor

Interventions

DRUG: capecitabine
DRUG: cisplatin
DRUG: streptozocin
GENETIC: DNA analysis
GENETIC: RNA analysis
GENETIC: protein analysis
GENETIC: proteomic profiling
OTHER: laboratory biomarker analysis

Sponsor

Cambridge University Hospitals NHS Foundation Trust